Granules India appoints Ovais Sarmad as sustainability advisor
Ovais Sarmad to guide Granules India on climate policy and environmental initiatives
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Granules India
Granules India presented with the Golden Peacock Award for sustainability
Granules India aims to achieve net zero emissions by 2050, in alignment with the Science Based Targets initiative (SBTi)
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
It is bioequivalent and therapeutically equivalent to the reference listed drug, Cuvposa Oral Solution, 1 mg/5 mL of Merz…
Granules India gains ANDA approval for Trazodone tablets
The current annual US market for Trazodone tablets is approximately $128 million, according to MAT Jun 2024, IQVIA/IMS Health
Granules India gets ANDA approval for Colchicine capsules
Colchicine Capsules are indicated for prophylaxis of gout flares in adults
Granules India’s Vizag facility completes US FDA inspection with zero 483 observations
This facility manufactures APIs and formulations of oncology and non-oncology products
Granules India gets ANDA approval for Pantoprazole Sodium DR tablets
Pantoprazole Sodium delayed-release tablets are indicated for short-term treatment of erosive esophagitis associated with GERD
Granules India, NIPER sign MoU to Dr Chigurupati Centre of Excellence in Innovative and Sustainable…
The collaboration will feature joint research initiatives, ensuring a seamless flow of knowledge between the industry and academia
Granules Pharma completes USFDA PADE Inspection with zero observations
The inspection was conducted at Granules Pharmaceuticals from July 31, 2023 to August 03, 2023
Granules India gets USFDA approval for Metoprolol Succinate ER Tablets
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure